Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postoperative Bevacizumab in Advanced Ovarian Cancer
NCT02022917Phase 2Completed
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Mar 2014
- Primary completion
- Jan 2021
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by Chang Gung Memorial Hospital. Started Mar 2014; status: completed.
02
Drugs
bevacizumab
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT02022917.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02022917.